<DOC>
	<DOCNO>NCT02567903</DOCNO>
	<brief_summary>Knee arthroscopy commonly perform orthopaedic procedure worldwide , , accord American Society Sports Medicine , 4 million procedure perform year . The risk venous thrombosis follow procedure considerable rate symptomatic event vary 0.9 % 4.6 % . It currently unknown high risk come consider short duration minimal tissue damage cause procedure . A factor may play role use tourniquet . A large majority orthopaedic surgeon prefer operate within 'dry field ' , obtain use tourniquet . Tourniquet apply surgery without risk . Although use orthopedic surgery widely accept standard procedure , tourniquet use lead loss muscle functional strength contractile speed , vessel wall damage nerve injury , next possibly increase risk venous thrombosis . In proposed study investigator investigate effect tourniquet local systemic marker hypoxia , inflammation , involvement endothelium , coagulation activation . A finding prominent activation coagulation system tourniquet use non-use create important opportunity prevent thromboembolic event patient , show knee arthroscopy perform adequately without use tourniquet . Furthermore , increase understand pathophysiology thrombosis .</brief_summary>
	<brief_title>Tourniquet Study : A Clinical Trial Into Effect Tourniquet Use Coagulation System</brief_title>
	<detailed_description>Background Knee arthroscopy commonly perform orthopaedic procedure worldwide , , accord American Society Sports Medicine , 4 million procedure perform year . The risk venous thrombosis follow procedure considerable rate symptomatic event vary 0.9 % 4.6 % . It currently unknown high risk come consider short duration minimal tissue damage cause procedure . A factor may play role use tourniquet . A large majority orthopaedic surgeon prefer operate within 'dry field ' , obtain use tourniquet . In proposed study investigator investigate effect tourniquet local systemic marker hypoxia , inflammation , involvement endothelium , coagulation activation . Objective To investigate effect tourniquet application coagulation system patient undergo knee arthroscopy . A finding prominent activation coagulation system tourniquet use non-use create important opportunity prevent thromboembolic event patient , show knee arthroscopy perform adequately without use tourniquet . Furthermore , increase understand pathophysiology thrombosis . Study Design In randomize , control clinical study investigator compare local systemic coagulation inflammation marker knee arthroscopy two group : 25 patient randomize arthroscopy tourniquet ( Group I ) 25 patient arthroscopy without tourniquet ( Group II ) . Inclusion exclusion criteria The patient recruit one hospital Gouda 6 month inclusion period . All patient 18 year , schedule meniscectomy , diagnostic arthroscopy removal corpus libera eligible inclusion . Patients exclude suffer kind coagulation disorder , use hormonal anticonception , case pregnancy puerperium , history venous thrombosis , major surgery cast-immobilisation low extremity past two month , neoplasm inflammatory disease , BMI &gt; 30 , use anticoagulant therapy . Patients generally receive spinal anaesthesia . Patients nevertheless expose type anaesthesia exclude well , keep effect anaesthesia equal participant . Intervention Patients randomized knee arthroscopy without tourniquet use knee arthroscopy tourniquet use . In patient randomize arthroscopy tourniquet use , exsanguination leg knee arthroscopy perform accomplished raise leg vertically one minute . The tourniquet inflate 100-150 mmHg systolic blood pressure . Data duration surgery duration tourniquet use collect . Blood collect cubital vein great saphenous vein arthroscopy knee analyze outcome parameter reflect hypoxic state , inflammatory reaction , involvement endothelium , procoagulant state thrombin formation . Main study endpoint ( primary ) Change parameter timepoints ; Before surgery ( blood drawn approximately 1 hour surgery ) , directly surgery ( blood drawn within 5 minute ) , 1 hour surgery analyze . Different pattern analyze explore effect tourniquet application coagulation system possible biological mechanism . A change ( increase decrease ) marker within one pattern , compare baseline measurement ( surgery ) , consider relevant shift pattern , thereby suggest involvement specific pathway . Outcome parameter reflect hypoxic state : - pH - pO2 - pCO2 - Lactate Outcome parameter reflect inflammatory reaction : - White Blood Cell Count ( WBCC ) - E-selectin - Neutrophil Extracellular trap ( NETs ) Outcome parameter reflect involvement endothelium : - Von Willebrand Factor ( vWF ) - Thrombomodulin - E-selectin Outcome parameter reflect procoagulant state thrombin formation : - Prothrombin fragment 1+2 - D-dimer - Plasmin Activator Inhibitor 1 ( PAI 1 ) - Tissue plasminogen activator ( tPA ) - Factor VIII - Thrombin Antithrombin complex ( TAT ) - Plasmin antiplasmin complex ( PAP ) Secondary study paramaters â€¢ Visibility arthroscopy technical difficulty score . Time Schedule Month 1-3 : Completion study protocol , procedure approval METC . Set database randomisation procedure . Instruction participate clinician surgery/anaesthesia staff . Month 4-6 : Inclusion patient , data collection . Month 7-8 : Laboratory test . Month 9-12 : Data analysis , write submission manuscript .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>Inclusion criterion Meniscectomy Diagnostic arthroscopy Removal corpus libera Exclusion Criteria Any kind coagulation disorder pregnant within 3 month childbirth Use hormonal anticonception A history venous thrombosis Had major surgery past two month A history castimmobilization low extremity past two month A neoplasm inflammatory disease A BMI &gt; 30 use anticoagulant therapy Any anaesthesia technique spinal anaesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>